Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ejiao for Improvement of Blood Deficiency
ChiCTR1900021651Phase 4Recruiting
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Not applicable comparing Ejiao with Placebo (2 arms). Primary endpoint: TCM symptom scale. Started Mar 2019; status: recruiting.
02
Drugs
colla corii asini
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR1900021651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021651.